Plant Comparison

Midland Hawthorn vs Great Mullein

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AMidland HawthornCrataegus laevigataRosaceaeFull monograph →
Plant BGreat MulleinVerbascum thapsusScrophulariaceaeFull monograph →

At a glance

Midland Hawthorn and Great Mullein: they share 4 indicated uses (arthritis / joint pain, inflammation (general), insomnia / sleeplessness, …); 2 pharmacological actions in common.

Midland HawthornGreat Mullein
Constituents23
Pharmacological actions44
Indicated uses78
Safety notes22
Cited sources2219
Indicated uses
Only Midland Hawthorn
Cardiovascular / heart healthMenstrual crampsMuscle spasm
Shared (4)
Arthritis / joint painInflammation (general)Insomnia / sleeplessnessSkin irritation
Only Great Mullein
BronchitisCancer (anticancer research)CoughRespiratory support
Pharmacological actions
Only Midland Hawthorn
AntioxidantAntispasmodic
Shared (2)
Anti-inflammatorySedative / sleep support
Only Great Mullein
Anticancer (preclinical)Expectorant

Evidence face-off — shared uses

ConditionMidland HawthornGreat MulleinVerdict
Arthritis / joint pain1/101/10Comparable evidence
Inflammation (general)1/101/10Comparable evidence
Insomnia / sleeplessness1/101/10Comparable evidence
Skin irritation1/105/10Stronger for Great Mullein

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Oligomeric proanthocyanidins and flavonoids[5]

The principal cardioactive and antioxidant constituents, the basis for extract standardisation.

ProanthocyanidinsFlavonoidsQuercetin
Phenolic acids

Additional antioxidant constituents of the flower, leaf and fruit.

Phenolic acidsChlorogenic acid
Iridoid glycosides (aucubin, catalpol)[2]

Anti-inflammatory iridoids contributing to the plant's traditional respiratory and anti-inflammatory use.

Iridoid glycosidesGlycosides
Saponins and mucilage[1]

Mucilage gives the soothing demulcent action; saponins contribute to the traditional expectorant effect.

SaponinsMucilage
Flavonoids[2]

Antioxidant flavonoids contributing to overall activity.

Flavonoids

Pharmacological Actions

Anti-inflammatory[9, 15, 16]
Antioxidant[2, 5, 6, 7, 8, 9, 15, 16]
Antispasmodic[2, 10, 11, 15, 16]

Antispasmodic (cramp easing)

Sedative / sleep support[12, 15, 16]
Anti-inflammatory[1, 2, 8, 9, 12, 13, 14]
Anticancer (preclinical)[4]
Expectorant[1, 2, 3, 12, 13, 14]
Sedative / sleep support[12, 13, 14]

Traditional & Indicated Uses

Arthritis / joint pain[15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cardiovascular / heart health[15, 16]Traditional · 1/10
Evidence: 1
Label: Cardiovascular / heart health
Inflammation (general)[15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Insomnia / sleeplessness[15, 16]Traditional · 1/10

inferred from sedative action

Evidence: 1
Label: Insomnia / sleeplessness
Menstrual cramps[15, 16]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Menstrual cramps
Muscle spasm[15, 16]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Muscle spasm
Skin irritation[15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Arthritis / joint pain[12, 13, 14]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Bronchitis[12, 13, 14]Traditional · 1/10

inferred from expectorant action

Evidence: 1
Label: Bronchitis
Cancer (anticancer research)[4]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Cough[1, 12, 13, 14]Good · 7/10

inferred from expectorant action

Evidence: 7
Label: Cough
Inflammation (general)[12, 13, 14]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Insomnia / sleeplessness[12, 13, 14]Traditional · 1/10

inferred from sedative action

Evidence: 1
Label: Insomnia / sleeplessness
Respiratory support[1, 12, 13, 14]Good · 7/10
Evidence: 7
Label: Respiratory support
Skin irritation[9, 12, 13, 14]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Skin irritation

Safety, Cautions & Contraindications

Safety note[15, 16]Caution

Generally safe and well tolerated. High doses may cause low blood pressure and sedation. May interact with cardiac glycosides (digoxin) and antihypertensive drugs. Consult a physician before using with existing heart medications.

Safety note[15, 16, 17]Info

Duke (2002) rates hawthorn (Crataegus spp., including C. laevigata) as a triple-plus herb (+++) with Commission E approval (score 2-3) for decreasing cardiac output in functional Stage II heart insufficiency (NYHA). Clinical evidence supports hawthorn standardized extracts (80-500 mg, standardized to flavonoids or procyanidins) for angina, arrhythmia, atherosclerosis, and hypertension. Hawthorn may potentiate digitalis and other cardiac medications and is not considered suitable for self-medication without professional guidance (Duke, 2002).

Safety note[12, 13, 14]Caution

Generally considered safe for short-term use. The tiny hairs on the leaves can cause irritation if tea is not properly filtered. No significant drug interactions documented. Not recommended during pregnancy or breastfeeding due to lack of safety data.

Safety note[12, 13, 14, 15]Caution

Duke (2002) rates mullein as ++ with clinical evidence (score 2) for its expectorant activity, consistent with Commission E approval for catarrh and inflammation of the respiratory tract. It functions as a demulcent and emollient for mucous membranes. Traditionally used for bronchitis, asthma, and earaches (oil infusion). Dose: 1.5–2 g dried flower or leaf as tea, three to four times daily. Duke notes an antiviral (antiherpetic) activity at the experimental level. The plant is generally well-tolerated with no known significant contraindications at therapeutic doses (Duke, 2002).

External Ids

Gbif: 8252683
Wikidata: Q159553
Gbif: 3171949
Wikidata: Q160095

Botanical Description

Small deciduous tree or large shrub with thorny branches and glossy, shallowly lobed leaves (less deeply cut than common hawthorn). Clusters of small, five-petalled white (occasionally pink) flowers with a strong scent appear in spring, followed by small red berries (haws), each usually containing two seeds (nutlets).[1]

Height: 4-8 m
Habit: Small deciduous, thorny tree or large shrub
Leaves: Glossy, shallowly lobed (less deeply cut than C. monogyna)
Flowers: Clusters of small, five-petalled white to pink, strongly scented flowers
Stem: Thorny branches; grey, fissured bark on older wood
Root: Deep, spreading root system
Fruit: Small red berry (haw), usually with two seeds
Flowering Period: April-May

Tall, stately biennial herb forming a low first-year rosette of large, soft, thick, densely woolly grey-green leaves; in the second year it sends up a single, tall, unbranched flowering spike densely packed with bright yellow, five-petalled flowers that open a few at a time.[1]

Height: 1-2 m (flowering stem, second year)
Habit: Tall, biennial herb; woolly basal rosette in year one, single tall flowering spike in year two
Leaves: Large, soft, thick, densely woolly grey-green, entire to faintly scalloped margin
Flowers: Bright yellow, five-petalled, densely packed along a tall unbranched spike
Stem: Single, tall, unbranched, woolly flowering stem (second year only)
Root: Stout taproot
Fruit: Small capsule with numerous tiny seeds
Flowering Period: June-September (second year)

Habitat

Grows in woodland, woodland edges, hedgerows and scrub, typically on richer, damper soils than common hawthorn; native to western and central Europe.[1]

Grows on dry, sunny waste ground, roadsides, disturbed soil and rocky slopes; native to Europe, North Africa and Asia and widely naturalised in North America and elsewhere.[1]

Harvesting

Flowers are picked as they open in spring, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn; all three parts are used, often combined, in hawthorn preparations.[1]

Parts: Flower, Fruit, Leaf
Season: Flower and leaf in spring; fruit in autumn

The flowers are picked individually as they open through summer (since they open only a few at a time and quickly fade once picked); leaves are gathered from the first-year rosette or second-year plant and dried, with care to filter out the fine leaf hairs, which can irritate the throat if not strained from tea.[1]

Parts: Flower, Leaf
Season: Flowers through summer as they open; leaf from rosette or flowering plant

Traditional Uses

Hawthorn flower, leaf and berry have a long European tradition, and substantial modern clinical study, as a cardiovascular tonic - supporting heart function, mild circulatory complaints and calming nervous tension - reflected in its traditional use for 'heart strengthening' and its modern standing as a well-studied botanical for mild heart failure symptoms.[1]

Great mullein has a long European and Native American tradition as a soothing demulcent and expectorant remedy for cough, bronchitis and irritated airways, and the flower has also been infused in oil as a traditional remedy for earache; the soft, woolly leaf gave rise to old names like 'flannel leaf' and 'velvet plant'.[1, 2]

Preparations

Standardised extract[1]

Leaf-and-flower extract standardised to flavonoid or oligomeric proanthocyanidin content, taken as tablets or capsules; the best-studied clinical form.

Infusion (flower or leaf)[1]

Dried flower or leaf infused in hot water and carefully strained (to remove fine irritant hairs) as a traditional demulcent cough and respiratory tea.

Dosage

Standardised extract[14]

The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.

Herbal tea[14]

The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.

Infusion[11]

The EU herbal monograph gives 1.5-2 g of the flower in 150 mL of boiling water as an infusion, three to four times daily (daily dose 4.5-8 g), in adolescents, adults and elderly; the infusion should be carefully strained to remove the irritant hairs. The monograph covers the FLOWER (Verbasci flos) only — it gives no posology for the leaf. Not recommended under 12 years. Educational reference only, not a prescription.

References

REF-0782, REF-0783, REF-0784, REF-1779, REF-1780, REF-1781, REF-1782, REF-1783, REF-1784, REF-1785, REF-1786, REF-1787, REF-1788
REF-1123, REF-1124, REF-1125, REF-1126, REF-1127, REF-1128, REF-1129, REF-1130, REF-1131, REF-1132

Drug Class Interactions

Safety note[18, 19, 20]Caution
Drug Class: cardiac-glycosides
Mechanism: Hawthorn has its own positive effect on the heart (a Cochrane review found it improves heart-failure symptoms and exercise tolerance) and shares P-glycoprotein handling with digoxin, so combining it with digoxin or other cardiac-glycoside heart drugs should be supervised even though a controlled study found no major change in digoxin levels.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[19, 20]Caution
Drug Class: antihypertensives
Mechanism: Hawthorn can mildly lower blood pressure and reduce cardiac oxygen demand (a Cochrane meta-analysis found a lower pressure-heart-rate product), which may add to the effect of blood-pressure and heart-failure medicines.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[21, 22]Caution
Drug Class: sedatives-cns-depressants
Mechanism: Hawthorn is traditionally used as a calming, sedative herb; taken with sedatives, sleeping tablets or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Not documented

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: has-lookalikes
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-06

Dangerous Lookalikes

Not documented

Safety note[16, 17, 18, 19]Fatal
Dangerous Plant: digitalis-purpurea
Confused Part: First-year basal leaf rosette (the foraged leaf, used for tea), before either plant sends up a flower spike.
Confusion Context: Foxglove is the dangerous look-alike for foraged soft-leaf rosettes: its poisonous first-year rosette resembles the plants people gather, and documented cardiac-glycoside poisonings have followed foxglove leaves eaten as comfrey or borage. Great mullein is foraged at the same woolly-rosette stage and grows in the same disturbed, sunny ground, so the same confusion applies. Foxglove leaves contain cardiac glycosides and can be fatal.
Distinguishing Features: Mullein leaves are densely, evenly woolly on BOTH surfaces — a thick silvery-grey felt that gives a soft blanket-like nap and largely hides the veins. Foxglove's upper surface is green and only thinly downy, never a thick silvery felt, and shows a sunken net of veins., Foxglove leaves have a distinctly toothed or scalloped margin; mullein margins are entire to only faintly scalloped. Use this only alongside the wool test, not on its own.
Key Test: Look at the UPPER surface: a thick, even, silvery wool that hides the veins = mullein. A green, matte, net-veined upper surface (only thinly hairy) with a toothed edge = foxglove — do not use it.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-06

References & Sources

  1. Fong, H.H.S. and Bauman, J.L (2002) 'Hawthorn', Journal of Cardiovascular Nursing, 16(4), pp. 1-8. doi:10.1097/00005082-200207000-00002 Traditional / reference
    https://doi.org/10.1097/00005082-200207000-00002
  2. Orhan, I.E (2018) 'Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb', Current Medicinal Chemistry, 25(37), pp. 4854-4865. doi:10.2174/0929867323666160919095519 Traditional / reference
    https://doi.org/10.2174/0929867323666160919095519
  3. Ahmadipour, B., Kalantar, M., Abaszadeh, S. and Hassanpour, H (2024) 'Antioxidant and antihyperlipidemic effects of hawthorn extract (Crataegus oxyacantha) in broiler chickens', Veterinary Medicine and Science, 10(3), pp. e1414. doi:10.1002/vms3.1414 Preclinical
    https://doi.org/10.1002/vms3.1414
  4. Rigelsky, J.M. and Sweet, B.V (2002) 'Hawthorn: pharmacology and therapeutic uses', American Journal of Health-System Pharmacy, 59(5), pp. 417-422. doi:10.1093/ajhp/59.5.417 Meta-analysis / review
    https://doi.org/10.1093/ajhp/59.5.417
  5. Saeedi, G., Jeivad, F., Goharbari, M., Gheshlaghi, G.H. and Sabzevari, O (2018) 'Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat', Drug Research, 68(10), pp. 553-559. doi:10.1055/a-0579-7532 Preclinical
    https://doi.org/10.1055/a-0579-7532
  6. Mecheri, A., Benabderrahmane, W., Amrani, A., Boubekri, N., Benayache, F., Benayache, S. and Zama, D (2019) 'Hepatoprotective Effects of Algerian Crataegus oxyacantha Leaves', Recent Patents on Food, Nutrition & Agriculture, 10(1), pp. 70-75. doi:10.2174/2212798410666180730095456 Preclinical
    https://doi.org/10.2174/2212798410666180730095456
  7. Benabderrahmane, W., Lores, M., Benaissa, O., Lamas, J.P., de Miguel, T., Amrani, A., Benayache, F. and Benayache, S (2019) 'Polyphenolic content and bioactivities of Crataegus oxyacantha L. (Rosaceae)', Natural Product Research, 35(4), pp. 627-632. doi:10.1080/14786419.2019.1582044 Preclinical
    https://doi.org/10.1080/14786419.2019.1582044
  8. Ali, M., Muhammad, S., Shah, M.R., Khan, A., Rashid, U., Farooq, U., Ullah, F., Sadiq, A., Ayaz, M., Ali, M., Ahmad, M. and Latif, A (2017) 'Neurologically Potent Molecules from Crataegus oxyacantha; Isolation, Anticholinesterase Inhibition, and Molecular Docking', Frontiers in Pharmacology, 8, pp. 327. doi:10.3389/fphar.2017.00327 Preclinical
    https://doi.org/10.3389/fphar.2017.00327
  9. Cuevas-Duran, R.E., Medrano-Rodriguez, J.C., Sanchez-Aguilar, M., Soria-Castro, E., Rubio-Ruiz, M.E., Del Valle-Mondragon, L., Sanchez-Mendoza, A., Torres-Narvaez, J.C., Pastelin-Hernandez, G. and Ibarra-Lara, L (2017) 'Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents', International Journal of Molecular Sciences, 18(11), pp. 2412. doi:10.3390/ijms18112412 Preclinical
    https://doi.org/10.3390/ijms18112412
  10. Alp, H., Soner, B.C., Baysal, T. and Sahin, A.S (2014) 'Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats', Anatolian Journal of Cardiology, 15(12), pp. 970-975. doi:10.5152/akd.2014.5869 Preclinical
    https://doi.org/10.5152/akd.2014.5869
  11. Rothfuss, M.A., Pascht, U. and Kissling, G (2001) 'Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats', Arzneimittel-Forschung, 51(1), pp. 24-28. doi:10.1055/s-0031-1299998 Preclinical
    https://doi.org/10.1055/s-0031-1299998
  12. Khan, A., Akram, M., Thiruvengadam, M., Daniyal, M., Zakki, S.A., Munir, N., Zainab, R., Heydari, M., Mosavat, S.H., Rebezov, M. and Shariati, M.A (2022) 'Anti-anxiety Properties of Selected Medicinal Plants', Current Pharmaceutical Biotechnology, 23(8), pp. 1041-1060. doi:10.2174/1389201022666210122125131 Meta-analysis / review
    https://doi.org/10.2174/1389201022666210122125131
  13. Rastogi, S., Pandey, M.M. and Rawat, A.K.S (2015) 'Traditional herbs: a remedy for cardiovascular disorders', Phytomedicine, 23(11), pp. 1082-1089. doi:10.1016/j.phymed.2015.10.012 Meta-analysis / review
    https://doi.org/10.1016/j.phymed.2015.10.012
  14. European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
    https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore
  15. Hendel, N. and Hendel, M (2014) 'Hedgerow Medicine'. Traditional / reference
    https://scholar.google.com/scholar?q=Hedgerow%20Medicine
  16. Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
    https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure
  17. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  18. Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
    https://doi.org/10.1177/0091270003253417
  19. Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD005312.pub2
  20. Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD005312.pub2
  21. Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
    https://doi.org/10.1002/ptr.8201
  22. Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
    https://doi.org/10.1177/1534735404265003
  1. Turker, A.U. and Gurel, E (2005) 'Common mullein (Verbascum thapsus L.): recent advances in research', Phytotherapy Research, 19(9), pp. 733-739. doi:10.1002/ptr.1653 Meta-analysis / review
    https://doi.org/10.1002/ptr.1653
  2. Gupta, A., Atkinson, A.N., Pandey, A.K. and Bishayee, A (2022) 'Health-promoting and disease-mitigating potential of Verbascum thapsus L. (common mullein): A review', Phytotherapy Research, 36(4), pp. 1507-1522. doi:10.1002/ptr.7393 Meta-analysis / review
    https://doi.org/10.1002/ptr.7393
  3. Ali, N., Ali Shah, S.W., Shah, I., Ahmed, G. and others (2012) 'Anthelmintic and relaxant activities of Verbascum thapsus (Mullein)', BMC Complementary and Alternative Medicine, 12, pp. 29. doi:10.1186/1472-6882-12-29 Preclinical
    https://doi.org/10.1186/1472-6882-12-29
  4. Mahdavi, S., Amiradalat, M., Babashpour, M., Sheikhlooei, H. and others (2020) 'The Antioxidant, Anticarcinogenic and Antimicrobial Properties of Verbascum thapsus L', Medicinal Chemistry, 16(7), pp. 991-995. doi:10.2174/1573406415666190828155951 Preclinical
    https://doi.org/10.2174/1573406415666190828155951
  5. Kashan, Z.F., Arbabi, M., Delavari, M., Hooshyar, H. and others (2015) 'Effect of Verbascum thapsus ethanol extract on induction of apoptosis in Trichomonas vaginalis in vitro', Infectious Disorders Drug Targets, 15(2), pp. 125-130. doi:10.2174/1871526515666150724114924 Preclinical
    https://doi.org/10.2174/1871526515666150724114924
  6. Chen, S., Liu, H., Wang, S., Jiang, H. and others (2022) 'The Neuroprotection of Verbascoside in Alzheimer's Disease Mediated through Mitigation of Neuroinflammation via Blocking NF-kappaB-p65 Signaling', Nutrients, 14(7), pp. 1417. doi:10.3390/nu14071417 Preclinical
    https://doi.org/10.3390/nu14071417
  7. Bampidis, V., Azimonti, G., Bastos, M.L. and others (EFSA FEEDAP Panel) (2021) 'Safety of a feed additive consisting of a tincture derived from Verbascum thapsus L. (great mullein tincture) for use in all animal species (MANGHEBATI SAS)', EFSA Journal, 19(7), pp. e06711. doi:10.2903/j.efsa.2021.6711 Meta-analysis / review
    https://doi.org/10.2903/j.efsa.2021.6711
  8. Blanco-Salas, J., Hortigon-Vinagre, M.P., Morales-Jadan, D. and Ruiz-Tellez, T (2021) 'Searching for Scientific Explanations for the Uses of Spanish Folk Medicine: A Review on the Case of Mullein (Verbascum, Scrophulariaceae)', Biology, 10(7), pp. 618. doi:10.3390/biology10070618 Meta-analysis / review
    https://doi.org/10.3390/biology10070618
  9. Taleb, S. and Saeedi, M (2021) 'The effect of Verbascum thapsus on episiotomy wound healing in nulliparous women: a randomized controlled trial', BMC Complementary Medicine and Therapies, 21(1), pp. 166. doi:10.1186/s12906-021-03339-6 Randomized trial
    https://doi.org/10.1186/s12906-021-03339-6
  10. Soto, K.M., Luzardo-Ocampo, I., Lopez-Romero, J.M., Mendoza, S. and others (2022) 'Gold Nanoparticles Synthesized with Common Mullein (Verbascum thapsus) and Castor Bean (Ricinus communis) Ethanolic Extracts Displayed Antiproliferative Effects and Induced Caspase 3 Activity in Human HT29 and SW480 Cancer Cells', Pharmaceutics, 14(10), pp. 2069. doi:10.3390/pharmaceutics14102069 Preclinical
    https://doi.org/10.3390/pharmaceutics14102069
  11. European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Verbascum thapsus L., V. densiflorum Bertol. and V. phlomoides L., flos (Verbasci flos)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/verbasci-flos Traditional / reference
    https://www.ema.europa.eu/en/medicines/herbal/verbasci-flos
  12. Oliff, H.S. and Blumenthal, M (2003) 'Great mullein', pp. 30--31. Traditional / reference
    https://scholar.google.com/scholar?q=Great%20mullein
  13. Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
    https://powo.science.kew.org
  14. Turker, A.U. and Gurel, E (2005) 'Common mullein (Verbascum thapsus L.): recent advances in research', 19(9), pp. 733--739. doi:10.1002/ptr.1653 Traditional / reference
    https://doi.org/10.1002/ptr.1653
  15. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  16. Lin, C.C. and Yang, C.C. and Phua, D.H. and Deng, J.F. and Lu, L.H (2010) 'An outbreak of foxglove leaf poisoning', Journal of the Chinese Medical Association, 73(2), pp. 97-100. doi:10.1016/S1726-4901(10)70009-5 Clinical study
    https://doi.org/10.1016/S1726-4901(10)70009-5
  17. Janssen, R.M. and Berg, M. and Ovakim, D.H (2016) 'Two cases of cardiac glycoside poisoning from accidental foxglove ingestion', CMAJ, 188(10), pp. 747-750. doi:10.1503/cmaj.150676 Clinical study
    https://doi.org/10.1503/cmaj.150676
  18. Woodland Trust (2024) 'Foxglove (Digitalis purpurea)'. Available at: https://www.woodlandtrust.org.uk/trees-woods-and-wildlife/plants/wild-flowers/foxglove/ Traditional / reference
    https://www.woodlandtrust.org.uk/trees-woods-and-wildlife/plants/wild-flowers/foxglove/
  19. NC State Extension (2024) 'Verbascum thapsus (Common Mullein)'. Available at: https://plants.ces.ncsu.edu/plants/verbascum-thapsus/ Traditional / reference
    https://plants.ces.ncsu.edu/plants/verbascum-thapsus/

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.